tiprankstipranks
Option Care Health Inc (OPCH)
NASDAQ:OPCH
US Market
Want to see OPCH full AI Analyst Report?

Option Care Health (OPCH) Stock Forecast & Price Target

557 Followers
See the Price Targets and Ratings of:

OPCH Analyst Ratings

Moderate Buy
12Ratings
Moderate Buy
8 Buy
4 Hold
0 Sell
Based on 12 analysts giving stock ratings to
Option
Care Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

OPCH Stock 12 Month Forecast

Average Price Target

$28.27
▲(30.53% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for Option Care Health in the last 3 months. The average price target is $28.27 with a high forecast of $39.00 and a low forecast of $22.00. The average price target represents a 30.53% change from the last price of $21.66.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"19":"$19","40":"$40","24.25":"$24.3","29.5":"$29.5","34.75":"$34.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":39,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$39.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":28.272727272727273,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$28.27</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":22,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$22.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[19,24.25,29.5,34.75,40],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,21.04,22.42153846153846,23.803076923076922,25.184615384615384,26.566153846153846,27.947692307692307,29.32923076923077,30.71076923076923,32.09230769230769,33.473846153846154,34.855384615384615,36.23692307692308,37.61846153846154,{"y":39,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,21.04,21.596363636363634,22.152727272727272,22.709090909090907,23.265454545454546,23.82181818181818,24.37818181818182,24.934545454545454,25.490909090909092,26.047272727272727,26.603636363636365,27.16,27.71636363636364,{"y":28.272727272727273,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,21.04,21.113846153846154,21.187692307692306,21.26153846153846,21.335384615384616,21.409230769230767,21.483076923076922,21.556923076923077,21.630769230769232,21.704615384615384,21.77846153846154,21.852307692307694,21.926153846153845,{"y":22,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":31.95,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.26,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.44,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.24,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 35, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.03,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 32, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.94,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.86,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.61,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.6,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 61,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 36, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.49,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 55,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 51, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.03,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 50,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 61, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.46,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 35, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.04,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$39.00Average Price Target$28.27Lowest Price Target$22.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stephens
$30$24
Hold
10.80%
Upside
Downgraded
07/17/26
Option Care Health downgraded to Equal Weight from Overweight at StephensOption Care Health downgraded to Equal Weight from Overweight at Stephens
UBS
$39
Buy
80.06%
Upside
Reiterated
06/16/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (NYSE: EW), High Tide (NASDAQ: HITI) and Option Care Health (NASDAQ: OPCH)
Goldman Sachs Analyst forecast on OPCH
Goldman Sachs
Goldman Sachs
$22
Hold
1.57%
Upside
Initiated
06/08/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (NASDAQ: INCY) and Option Care Health (NASDAQ: OPCH)
William Blair Analyst forecast on OPCH
William Blair
William Blair
Buy
Reiterated
06/01/26
Analysts Offer Insights on Healthcare Companies: MannKind (NASDAQ: MNKD) and Option Care Health (NASDAQ: OPCH)
Morgan Stanley Analyst forecast on OPCH
Morgan Stanley
Morgan Stanley
$38$28
Buy
29.27%
Upside
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: Revvity (NYSE: RVTY), Option Care Health (NASDAQ: OPCH) and OnKure Therapeutics (NASDAQ: OKUR)
J.P. Morgan Analyst forecast on OPCH
J.P. Morgan
J.P. Morgan
$40$33
Buy
52.35%
Upside
Assigned
05/04/26
Option Care Health price target lowered to $33 from $40 at JPMorganOption Care Health price target lowered to $33 from $40 at JPMorgan
Truist Financial Analyst forecast on OPCH
Truist Financial
Truist Financial
$40$30
Buy
38.50%
Upside
Reiterated
05/01/26
Truist Financial Reaffirms Their Buy Rating on Option Care Health (OPCH)
Deutsche Bank  Analyst forecast on OPCH
Deutsche Bank
Deutsche Bank
$38$26
Buy
20.04%
Upside
Reiterated
05/01/26
Option Care Health price target lowered to $26 from $38 at Deutsche BankOption Care Health price target lowered to $26 from $38 at Deutsche Bank
Bank of America Securities Analyst forecast on OPCH
Bank of America Securities
Bank of America Securities
$22
Hold
1.57%
Upside
Downgraded
05/01/26
Option Care Health downgraded to Neutral from Buy at BofAOption Care Health downgraded to Neutral from Buy at BofA
Barrington Analyst forecast on OPCH
Barrington
Barrington
$42$32
Buy
47.74%
Upside
Reiterated
05/01/26
Option Care Health price target lowered to $32 from $42 at BarringtonOption Care Health price target lowered to $32 from $42 at Barrington
TD Cowen
$37$23
Hold
6.19%
Upside
Assigned
04/30/26
Option Care Health: Execution Risks, CID Headwinds Prompt EBITDA Cut and Price Target Reduction to $23, Supporting Hold Rating
Citizens JMP
$38$32
Buy
47.74%
Upside
Reiterated
04/30/26
Option Care Health price target lowered to $32 from $38 at CitizensOption Care Health price target lowered to $32 from $38 at Citizens
Jefferies Analyst forecast on OPCH
Unknown Analyst
Jefferies
Not Ranked
Jefferies
$43
Buy
98.52%
Upside
Reiterated
03/25/26
Jefferies Sticks to Its Buy Rating for Option Care Health (OPCH)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stephens
$30$24
Hold
10.80%
Upside
Downgraded
07/17/26
Option Care Health downgraded to Equal Weight from Overweight at StephensOption Care Health downgraded to Equal Weight from Overweight at Stephens
UBS
$39
Buy
80.06%
Upside
Reiterated
06/16/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (NYSE: EW), High Tide (NASDAQ: HITI) and Option Care Health (NASDAQ: OPCH)
Goldman Sachs Analyst forecast on OPCH
Goldman Sachs
Goldman Sachs
$22
Hold
1.57%
Upside
Initiated
06/08/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (NASDAQ: INCY) and Option Care Health (NASDAQ: OPCH)
William Blair Analyst forecast on OPCH
William Blair
William Blair
Buy
Reiterated
06/01/26
Analysts Offer Insights on Healthcare Companies: MannKind (NASDAQ: MNKD) and Option Care Health (NASDAQ: OPCH)
Morgan Stanley Analyst forecast on OPCH
Morgan Stanley
Morgan Stanley
$38$28
Buy
29.27%
Upside
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: Revvity (NYSE: RVTY), Option Care Health (NASDAQ: OPCH) and OnKure Therapeutics (NASDAQ: OKUR)
J.P. Morgan Analyst forecast on OPCH
J.P. Morgan
J.P. Morgan
$40$33
Buy
52.35%
Upside
Assigned
05/04/26
Option Care Health price target lowered to $33 from $40 at JPMorganOption Care Health price target lowered to $33 from $40 at JPMorgan
Truist Financial Analyst forecast on OPCH
Truist Financial
Truist Financial
$40$30
Buy
38.50%
Upside
Reiterated
05/01/26
Truist Financial Reaffirms Their Buy Rating on Option Care Health (OPCH)
Deutsche Bank  Analyst forecast on OPCH
Deutsche Bank
Deutsche Bank
$38$26
Buy
20.04%
Upside
Reiterated
05/01/26
Option Care Health price target lowered to $26 from $38 at Deutsche BankOption Care Health price target lowered to $26 from $38 at Deutsche Bank
Bank of America Securities Analyst forecast on OPCH
Bank of America Securities
Bank of America Securities
$22
Hold
1.57%
Upside
Downgraded
05/01/26
Option Care Health downgraded to Neutral from Buy at BofAOption Care Health downgraded to Neutral from Buy at BofA
Barrington Analyst forecast on OPCH
Barrington
Barrington
$42$32
Buy
47.74%
Upside
Reiterated
05/01/26
Option Care Health price target lowered to $32 from $42 at BarringtonOption Care Health price target lowered to $32 from $42 at Barrington
TD Cowen
$37$23
Hold
6.19%
Upside
Assigned
04/30/26
Option Care Health: Execution Risks, CID Headwinds Prompt EBITDA Cut and Price Target Reduction to $23, Supporting Hold Rating
Citizens JMP
$38$32
Buy
47.74%
Upside
Reiterated
04/30/26
Option Care Health price target lowered to $32 from $38 at CitizensOption Care Health price target lowered to $32 from $38 at Citizens
Jefferies Analyst forecast on OPCH
Unknown Analyst
Jefferies
Not Ranked
Jefferies
$43
Buy
98.52%
Upside
Reiterated
03/25/26
Jefferies Sticks to Its Buy Rating for Option Care Health (OPCH)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BBOTBridgeBio Oncology Therapeutics
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Option Care Health

3 Months
Pito ChickeringDeutsche Bank
Success Rate
9/17 ratings generated profit
53%
Average Return
+1.85%
Copying Pito Chickering's trades and holding each position for 3 Months would result in 52.94% of your transactions generating a profit, with an average return of +1.85% per trade.
1 Year
Pito ChickeringDeutsche Bank
Success Rate
13/17 ratings generated profit
76%
Average Return
+9.18%
reiterated a buy rating 3 months ago
Copying Pito Chickering's trades and holding each position for 1 Year would result in 76.47% of your transactions generating a profit, with an average return of +9.18% per trade.
2 Years
Pito ChickeringDeutsche Bank
Success Rate
9/17 ratings generated profit
53%
Average Return
+5.81%
Copying Pito Chickering's trades and holding each position for 2 Years would result in 52.94% of your transactions generating a profit, with an average return of +5.81% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

OPCH Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
2
4
7
6
4
Buy
59
51
43
15
9
Hold
36
51
61
35
17
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
97
106
111
56
30
In the current month, OPCH has received 13 Buy Ratings, 17 Hold Ratings, and 0 Sell Ratings. OPCH average Analyst price target in the past 3 months is 28.27.
Each month's total comprises the sum of three months' worth of ratings.

OPCH Financial Forecast

OPCH Earnings Forecast

Next quarter’s earnings estimate for OPCH is $0.48 with a range of $0.46 to $0.49. The previous quarter’s EPS was $0.45. OPCH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 58.33% of the time in the same period. In the last calendar year OPCH has Performed in-line its overall industry.
Next quarter’s earnings estimate for OPCH is $0.48 with a range of $0.46 to $0.49. The previous quarter’s EPS was $0.45. OPCH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 58.33% of the time in the same period. In the last calendar year OPCH has Performed in-line its overall industry.

OPCH Sales Forecast

Next quarter’s sales forecast for OPCH is $1.45B with a range of $1.44B to $1.46B. The previous quarter’s sales results were $1.44B. OPCH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 66.67% of the time in the same period. In the last calendar year OPCH has Performed in-line its overall industry.
Next quarter’s sales forecast for OPCH is $1.45B with a range of $1.44B to $1.46B. The previous quarter’s sales results were $1.44B. OPCH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 66.67% of the time in the same period. In the last calendar year OPCH has Performed in-line its overall industry.

OPCH Stock Forecast FAQ

What is OPCH’s average 12-month price target, according to analysts?
Based on analyst ratings, Option Care Health Inc’s 12-month average price target is 28.27.
    What is OPCH’s upside potential, based on the analysts’ average price target?
    Option Care Health Inc has 30.53% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is OPCH a Buy, Sell or Hold?
          Option Care Health Inc has a consensus rating of Moderate Buy which is based on 8 buy ratings, 4 hold ratings and 0 sell ratings.
            What is Option Care Health Inc’s price target?
            The average price target for Option Care Health Inc is 28.27. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $39.00 ,the lowest forecast is $22.00. The average price target represents 30.53% Increase from the current price of $21.66.
              What do analysts say about Option Care Health Inc?
              Option Care Health Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of OPCH?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.